Apr 20, 2024
Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson’s disease
Posted by Genevieve Klien in categories: biotech/medical, nanotechnology, neuroscience
Is it possible for nanoparticles to go through the digestive system and deliver medicine directly to the brain tissue? Researchers from Michigan State University say yes, and their latest findings are expected to benefit patients with neurodegenerative disorders like multiple sclerosis, or MS; amyotrophic lateral sclerosis, or ALS; and Parkinson’s disease, or PD.